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Abstract hTrp3 is a human homologue of the Drosophila gene
responsible for a transient receptor potential (trp) mutation.
When stably expressed in HEK293 cells, hTrp3 formed ion
channels that were active under resting conditions but could be
further stimulated by carbachol or ATP via endogenous
muscarinic or purinergic receptors, respectively. Agonist evoked
currents reversed polarity near 0 mV in physiological ionic
conditions and were associated with a significant increase in the
current variance. These results suggest the involvement of a non-
selective cation channel with relatively large unitary amplitude.
Consistent with this, resolved unitary events had a conductance
of approximately 60 pS in the negative voltage range and an
extrapolated reversal potential near 0 mV.
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1. Introduction
Unlike phototransduction in the vertebrate eye, the photo-
receptors in Drosophila, like most invertebrates, depolarize in
response to light (for review, see [1]). In the Drosophila photo-
receptor, light mediated membrane depolarization involves
the opening of two homologous cation channels, DTrp (Dro-
sophila transient receptor potential) and DTrpl (Trp-like).
These channels open in response to the G-protein mediated
activation of phospholipase C (PLC) and subsequent break-
down of phosphatidyl inositol 4,5-bisphosphate (PIP2) (for
reviews, see [1^4]). In addition to their excitatory role, these
channels play a crucial role in the re¢lling of Ca2 stores by
allowing Ca2 to £ow into the cell from the extracellular
environment, an important process for light adaptation. In-
deed, the Drosophila trp mutant becomes blinded by intense
light as it is not able to mount a Ca2-dependent light adap-
tation response [5,6].
The cDNAs encoding Drosophila Trp and Trpl have been
cloned and functionally expressed in heterologous cell systems
[7^14]. DTrp is a Ca2 selective channel that is activated by an
unknown mechanism associated with the release of Ca2 from
endoplasmic reticulum stores [11,12]. DTrpl is a non-selective
cation channel that is activated by G-protein coupled signal-
ing pathways but opens independently of the ¢lling state of
Ca2 stores [9^11,13^16]. Both IP3 [9] and G proteins of the
Gq=11 subfamily [16] have been implicated as important signal-
ing molecules for the activation of DTrpl.
Several mammalian homologues of DTtrp and DTrpl have
recently been cloned and functionally expressed [17^21]. One
such gene, hTrp3, when co-transfected with the muscarinic
M5 receptor into COS cells, increases Ca2 in£ux in response
to the muscarinic agonist carbachol (CCh) [18]. The aim of
the present work was to characterize the ionic currents under-
lying the hTrp3 mediated agonist evoked Ca2 in£ux. The
experiments described here were performed by measuring
ionic currents from HEK293 cells stably expressing hTrp3
using the perforated patch-clamp technique.
2. Materials and methods
2.1. Nomenclature
DTrp is the protein encoded by the Drosophila trp gene; DTrpl is
the protein encoded by the Drosophila trp-like gene; hTrp3 is the
protein encoded by the hTrp3 gene; D = Drosophila, h = human;
Trp3 cells are HEK293 cells stably expressing hTrp3.
2.2. Stable expression of hTrp3 in HEK293 cells
HEK293 cells were cultured in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) containing 4.5 mg/ml glucose, 10% heat-inactivated fetal
bovine serum, 50 units/ml penicillin, and 50 Wg/ml streptomycin. Sta-
ble cell lines expressing hTrp3 were developed by transfection of
cDNA encoding hTrp3 containing a hemagglutinin (HA) epitope at
the C terminus in pcDNA3 vector by the calcium phosphate/glycerol
shock method [22]. After 24 h, cells were harvested, diluted in medium
supplemented with 400 Wg/ml G418, and transferred to wells of 96-
well plates at di¡erent dilutions. G418-resistant transformants were
expanded into 12-well plates. Cell lines expressing the HA epitope
were identi¢ed by immunocytochemical staining in 96-well plates as
described by Vannier et al. [23] using a monoclonal HA antibody,
12CA5 (Babco Inc., Berkeley, CA, USA), as the primary antibody
and anti-mouse IgG conjugated with peroxidase (Amersham) as the
secondary antibody. Expression of HA-tagged hTrp3 in stain-positive
cell lines was con¢rmed by immunoprecipitation with 12CA5 as de-
scribed [24]. Two cell lines were used for electrophysiological analysis.
Two G418-resistant control cell lines were selected from HEK293 cells
stably transfected with cDNA encoding rat V1a vasopressin receptor
in pcDNA3 developed similarly as the Trp3 cell lines. The stable cell
lines were diluted twice weekly and maintained in medium supple-
mented with 400 Wg/ml G418. For electrophysiological recordings,
cells were seeded on circular coverslips (5 mm in diameter) pre-coated
with poly-D-lysine (100 Wg/ml). Detailed results on immunoprecipita-
tion of hTrp3 from the Trp3 cells and the e¡ect of hTrp3 expression
on Ca2 in£ux of HEK293 cells in response to receptor activation and
store depletion are described elsewhere [25].
2.3. Electrophysiology
Stably transfected HEK293 cells were voltage-clamped using the
perforated patch-clamp technique [26]. Patch pipettes (2^5 M6)
were ¢lled by ¢rst adding a pipette solution free of nystatin. The
remainder of the pipette was back ¢lled with the same solution con-
taining nystatin (50 Wg/ml). The pipette solution was composed of the
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following (in mM): potassium methanesulfonate 130, KCl 10, CaCl2
0.5, MgCl2 2.0, EGTA 5.0, Na-HEPES 5.0, pH 7.2 (V280 mosM).
Nystatin was diluted into the pipette solution about every 3 h from a
50 mg/ml stock in dimethylsulfoxide (DMSO). All patch pipettes were
pulled from borosilicate glass capillary tubing (Warner Instrument
Corp., Hamden, CT). The bath was composed of the following (in
mM): NaCl 140, KCl 5.0, CaCl2 1.8, MgCl2 1.0, glucose 10, HEPES
15, pH 7.4 (V305 mosM). Carbachol, atropine, ATP and LaCl3 were
diluted into the bath solution from stock solutions dissolved in water.
In experiments measuring current at a constant potential, the cur-
rent was digitized at 400 Ws/point after being ¢ltered at 400 Hz. In
single channel experiments, the current was digitized at 200 Ws/point
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Fig. 1. hTrp3 mediated CCh evoked current. Response of Trp3 cells (left panels; A,C,E) and control cell (right panels; B,D) to stimulation by
CCh. A and B: Mean current (negative values) and current variance (positive values) recorded during repeated 200 ms sweeps at a holding po-
tential of 360 mV. The horizontal bars indicate the presence of CCh (100 WM). C and D: Individual sweeps of 200 ms at 360 mV before (a
and aP) and during (b and bP) the application of CCh and after its wash-out (c and cP). Sweeps were taken from the regions in A and B indi-
cated with lower case letters. The capacity of the Trp3 and control cell was 21.9 pF and 21.0 pF, respectively. E: Mean current and current
variance evoked from a di¡erent Trp3 cell challenged with CCh (100 WM, solid bar) þ the co-application of atropine (1 WM, open bar); the ca-
pacity of this cell was 16.7 pF.
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and ¢ltered at 1 kHz. Voltage ramps were delivered from 380 mV to
20 mV over 200 ms, data were acquired at 500 Ws/point and ¢ltered at
400 Hz. All experiments were performed at room temperature.
2.4. Data analysis
Evoked current in response to drug application was quanti¢ed by
subtracting the average current preceding drug application (control
value) from the peak inward current measured during drug applica-
tion. Similarly, the evoked variance was quanti¢ed by subtracting the
control variance preceding drug application from the maximum var-
iance measured during drug application. Averaged data were normal-
ized to 20 pF of membrane capacity which was approximately the
average cell capacity of 20.7 þ 0.9 pF ( þ S.E., n = 78). The ratio of
current variance to mean current was derived from the linear regres-
sion ¢t to the variance as a function of the mean current in individual
cells. Reversal potentials were estimated from macroscopic current
recordings by ¢tting a linear regression to the data between 380
and 320 mV and extrapolating the ¢t to the zero current potential.
All data are represented as the mean þ S.E. and n = number of cells.
Statistical analyses were performed with the two-tailed Student’s t
distribution.
3. Results and discussion
3.1. Agonist evoked hTrp3 currents
When challenged with CCh, Trp3 cells rapidly developed an
inward current at 360 mV that decayed to a small plateau
upon continued exposure to the agonist for up to 100 s (Fig.
1A). The current further decayed back to its resting value
when CCh was washed out. Similar results were observed in
two di¡erent HEK293 cell lines stably transfected with hTrp3.
CCh evoked currents were always associated with an in-
creased noise or current variance (Fig. 1A,C) that most likely
re£ects a relatively small number of non-synchronous channel
openings and closings upon CCh stimulation [27,28]. Both the
CCh evoked current and increased current noise were rever-
sibly blocked by atropine, a speci¢c antagonist of the muscar-
inic receptor (Fig. 1E). In contrast to the Trp3 cells, CCh did
not evoke either a measurable current or current variance in
two di¡erent control cell lines that were stably transfected
with the rat V1a vasopressin receptor (Fig. 1B,D, see also
Fig. 2).
The purinergic receptor agonist ATP, which also stimulates
a Gq=11 protein, evoked a similar inward current when bath
applied to Trp3 cells voltage clamped at 360 mV (Fig. 2A).
ATP evoked current, like that of CCh, was associated with an
increased current variance (Fig. 2B). Both of these e¡ects were
reversed upon wash-out of ATP. There was no measurable
increase in either the current amplitude or current variance
in control cells treated with the same concentration of ATP.
Since CCh and ATP act through a common signaling path-
way, the currents evoked from Trp3 cells by either agonist
should be mediated by the same underlying channels. Consis-
tent with this idea, the ratio of current variance to current
amplitude, which gives a lower estimate of the single channel
amplitude [27^29] was not di¡erent for currents evoked by
these two agonist (Ps 0.5). The mean ratio of variance to
mean current at 360 mV was 30.6 þ 0.1 pA2/pA (n = 15)
for currents evoked by CCh and 30.7 þ 0.1 pA2/pA (n = 7)
for currents evoked by ATP. The similar ratio of current
variance to mean current suggests that the channels under-
lying CCh and ATP stimulated current had a similar single
channel amplitude at this potential.
3.2. Current-voltage properties
Voltage ramps from 380 mV to 20 mV were applied to
Trp3 cells before and after addition of CCh to determine
the reversal potential of the evoked current in physiological
ionic conditions using the nystatin perforated patch-clamp
technique [26]. CCh evoked currents were approximately lin-
ear in the voltage range between 380 mV and 320 mV and
reversed at 1 þ 2 mV (n = 5) suggesting a non-selective cation
current with little voltage dependence over this voltage range
(Fig. 3A). A relatively large endogenous voltage-dependent
current present in both the Trp3 cells and control cells often
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Fig. 2. CCh and ATP evoked current and current variance. Bar plots of the mean evoked current (A) and current variance (B) from Trp3 and
control cells elicited by either CCh (100 or 200 WM) or ATP (100 WM). Individual values were obtained by subtracting the baseline current (i.e.
current prior to agonist exposure) from the peak inward current during the agonist application. There was no di¡erence in the evoked current
amplitude by 100 WM (n = 5) and 200 WM (n = 13) CCh (Ps 0.2). The data were normalized to 20 pF which is approximately the average cell
capacity of 20.7 þ 0.9 pF (n = 78). Numbers in parentheses are the number of cells tested and error bars show the S.E.M.
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obscured the smaller CCh evoked currents at potentials pos-
itive to about 320 mV, therefore no conclusion can be drawn
from these data regarding the linearity of the current-voltage
relationship at more positive potentials.
During the course of this work, we recorded from three
di¡erent Trp3 cells that had a combination of a small evoked
whole-cell current and high input resistance (15.4, 18.5 and 6.2
G6). This combination allowed the resolution of apparent
single channel events in the presence of CCh. While many
of the events were fast and probably truncated by the ¢lter
(1 kHz), some events appeared longer with discernible am-
plitudes (Fig. 3C). By manually measuring the amplitudes
of these resolved events, a single channel current-voltage
relationship (i-V) was constructed for each of the three
cells (Fig. 3B). The mean conductance determined by this
analysis was 59 þ 2 pS (n = 3). Supporting the validity of
this measurement, the extrapolated reversal potential for the
three i-V curves was 0 þ 4 mV (n = 3), consistent with the
results obtained from the macroscopic current-voltage rela-
tionship.
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Fig. 3. Macroscopic and single channel current-voltage relationship. A: CCh evoked current-voltage relationship was obtained by subtracting
current recorded prior to CCh stimulation from the current measured during bath application of CCh (200 WM). Voltage ramps were given
from 380 mV to +20 mV over 200 ms. The average of 11 ramps prior to CCh stimulation and 6 ramps during CCh exposure were used for
this analysis. The continuous straight line shows the linear regression ¢tted to the data between 380 and 320 mV. The dashed line is the ex-
trapolation of the ¢t through the reversal potential. B: Current voltage relationship obtained by manually measuring the amplitude of single
channel events from three di¡erent Trp3 cells (circles, squares and triangles). Five measurements were averaged per cell at every potential. The
continuous line is a linear regression ¢tted to the mean values. The dashed line is the extrapolation to the zero current potential. C: Individual
current sweeps obtained at 340 mV, 360 mV and 380 mV showing downward channel openings. The dashed horizontal lines indicate the uni-
tary channel amplitude.
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3.3. Constitutive channel activity
Most Trp3 cells tested displayed some level of channel ac-
tivity before the cell was ever exposed to agonist. This basal
activity ranged from individual channel openings to several
picoamps of mean current in which single events could not
be resolved (Fig. 4A^C). Most cells tested had a basal activity
somewhere within the range of that shown in Fig. 4A,B. The
basal channel activity was not measurably reduced by atro-
pine (1 or 3 WM, n = 7/7) but was completely blocked by the
non-speci¢c Ca2 channel blocker La3 at 200 WM (n = 7/7;
Fig. 4D).
Two lines of evidence suggest that the channels underlying
the basal activity resulted from the expression of hTrp3 and
were not endogenous to the HEK293 cells. First, no such
activity was every observed in two di¡erent control HEK293
cell lines expressing rat V1a vasopressin receptors and were
otherwise maintained under identical conditions (n = 31). Sec-
ond, the basal activity for hTrp3 had a similar ratio of var-
iance to mean current as the agonist evoked response. The
ratio of variance to mean current for the basal activity was
30.6 þ 0.1 pA2/pA (n = 7) compared to 30.6 pA2/pA and
30.7 pA2/pA for CCh and ATP evoked current, respectively
(see above). Only those cells that had a basal inward current
v39 pA that could be completely blocked by La3 (200 WM)
were considered for this analysis (n = 7; the mean basal cur-
rent of those cells was 315.4 þ 2.0 pA). Though the mecha-
nism underlying this basal channel activity is not known, it
should be noted that this constitutive activity is reminiscent of
that seen with Drosophila Trpl expressed in Sf9 cells
[10,11,15,30].
4. Conclusions
The main ¢ndings described in this work are the following.
(1) Stable expression of hTrp3 in HEK293 cells resulted in
constitutive channel activity that could be increased by ago-
nist of Gq=11 protein coupled receptors; neither component
was observed in control cells. (2) The evoked currents were
voltage independent in the range of 380 mV to 320 mV and
reversed polarity near 0 mV under physiological ionic condi-
tions. (3) Single channel events had a slope conductance of
about 60 pS in the negative voltage range and had an extrapo-
lated reversal potential near 0 mV in physiological ionic con-
ditions.
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